Welcome to Paid Research Studies




  • Condition:   Fanconi Anemia
    Intervention:   Genetic: Gene-modified autologous stem cells
    Sponsor:   Shenzhen Geno-Immune Medical Institute
    Recruiting

  • Condition:   Fanconi Anemia Complementation Group A
    Intervention:   Biological: RP-L102
    Sponsor:   Rocket Pharmaceuticals Inc.
    Recruiting

  • Condition:   Fanconi Anemia
    Intervention:   Drug: Quercetin (dietary supplement)
    Sponsors:   Children's Hospital Medical Center, Cincinnati;   Food and Drug Administration (FDA)
    Recruiting

  • Condition:   Fanconi's Anemia
    Intervention:   Drug: Eltrombopag
    Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting

  • Condition:   Fanconi Anemia
    Interventions:   Biological: Anti-Thymocyte Globulin;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Procedure: Hematopoietic Stem Cell Transplantation;   Drug: Methylprednisolone;   Drug: Filgrastim;   Drug: Cyclosporine;   Drug: Mycophenolate Mofetil
    Sponsor:   Masonic Cancer Center, University of Minnesota
    Recruiting

  • Condition:   Fanconi Anemia
    Interventions:   Biological: anti-thymocyte globulin;   Biological: filgrastim;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Drug: methylprednisolone;   Biological: Hematopoietic stem cell transplantation
    Sponsor:   Masonic Cancer Center, University of Minnesota
    Recruiting

  • Condition:   Fanconi Anemia
    Interventions:   Drug: Cyclophosphamide;   Drug: Fludarabine;   Procedure: Total Body Irradiation;   Procedure: Bone Marrow Transplantation;   Drug: Mycophenolate Mofetil;   Drug: Sirolimus
    Sponsor:   Masonic Cancer Center, University of Minnesota
    Recruiting

  • Condition:   Fanconi Anemia
    Interventions:   Procedure: IV administration of Genetically Engineered Hematopoietic Stem/Progenitors Cells (HSPCs);   Biological: Genetically Engineered Hematopoietic Stem/Progenitor Cells;   Other: Laboratory Biomarker Analysis;   Biological: Filgrastim;   Drug: Plerixafor;   Procedure: Bone Marrow Aspiration
    Sponsors:   Hospital Infantil Universitario Niño Jesús, Madrid, Spain;   Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT);   Centro de Investigación en Red de Enfermedades Raras (CIBERER);   Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz;   Hospital Vall d'Hebron;   Universitat Autonoma de Barcelona
    Recruiting

  • Conditions:   Fanconi Anemia;   Squamous Cell Carcinoma
    Intervention:   Drug: Quercetin (dietary supplement)
    Sponsor:   Children's Hospital Medical Center, Cincinnati
    Recruiting

  • Conditions:   Fanconi Anemia;   Severe Aplastic Anemia;   Myelodysplastic Syndromes
    Interventions:   Drug: Total Body Irradiation (TBI) (Plan 1);   Drug: Cyclophosphamide (CY) (Plan 1);   Drug: Fludarabine (FLU);   Drug: Methylprednisolone (MP);   Device: Donor mobilized PBSC infusion;   Drug: G-CSF;   Drug: Cyclophosphamide (CY) (Plan 2);   Drug: Rituximab
    Sponsor:   Masonic Cancer Center, University of Minnesota
    Recruiting

  • Conditions:   Fanconi Anemia;   Myelodysplastic Syndrome (MDS);   Acute Myelogenous Leukemia (AML)
    Interventions:   Drug: Busulfan;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Anti-Thymocyte Globulin (Rabbit);   Device: The CliniMACS device;   Drug: G-CSF
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Pediatric Brain Tumor Consortium
    Recruiting

  • Conditions:   Fanconi Anemia;   Severe Marrow Failure;   Myelodysplastic Syndrome (MDS);   Acute Myelogenous Leukemia (AML)
    Interventions:   Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: rabbit ATG;   Drug: G-CSF;   Biological: Peripheral blood stem cell
    Sponsors:   Children's Hospital Medical Center, Cincinnati;   Memorial Sloan Kettering Cancer Center;   Fred Hutchinson Cancer Research Center
    Recruiting

  • Conditions:   Renal Fanconi Syndrome;   Photophobia;   Hypophosphatemia
    Intervention:  
    Sponsor:   Centogene AG Rostock
    Recruiting

  • Conditions:   Diamond Blackfan Anemia;   Dyskeratosis Congenita;   Fanconi Anemia;   Shwachman Diamond Syndrome;   Inherited Bone Marrow Failure Syndrome, Aplastic Anemia
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Nephropathic Cystinosis
    Intervention:   Other: Blood sampling
    Sponsor:   Hospices Civils de Lyon
    Not yet recruiting

  • Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immune Deficiency;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi Anemia;   Thalassemia;   Sickle Cell Disease
    Intervention:  
    Sponsor:   University of California, San Francisco
    Recruiting

  • Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease
    Intervention:  
    Sponsor:   University of California, San Francisco
    Recruiting

  • Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease
    Intervention:  
    Sponsor:   University of California, San Francisco
    Recruiting

  • Conditions:   Acute Leukemia;   Adenomatous Polyposis;   Adrenocortical Carcinoma;   AML;   BAP1 Tumor Predisposition Syndrome;   Carney Complex;   Choroid Plexus Carcinoma;   Constitutional Mismatch Repair Deficiency Syndrome;   Diamond-Blackfan Anemia;   DICER1 Syndrome;   Dyskeratosis Congenita;   Emberger Syndrome;   Familial Acute Myeloid Leukemia;   Familial Adenomatous Polyposis;   Fanconi Anemia;   Familial Cancer;   Familial Wilms Tumor;   Familial Neuroblastoma;   GIST;   Hereditary Breast and Ovarian Cancer;   Hereditary Paraganglioma-Pheochromocytoma Syndrome;   Hodgkin Lymphoma;   Juvenile Polyposis;   Li-Fraumeni Syndrome;   Lynch Syndrome;   MDS;   Melanoma Syndrome;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Neuroblastoma;   Neurofibromatosis Type 1;   Neurofibromatosis Type II;   Nevoid Basal Cell Carcinoma Syndrome;   Non Hodgkin Lymphoma;   Noonan Syndrome and Other Rasopathy;   Overgrowth Syndromes;   Pancreatic Cancer;   Peutz-Jeghers Syndrome;   Pheochromocytoma/Paraganglioma;   PTEN Hamartoma Tumor Syndrome;   Retinoblastoma;   Rhabdoid Tumor Predisposition Syndrome;   Rhabdomyosarcoma;   Rothmund-Thomson Syndrome;   Tuberous Sclerosis;   Von Hippel-Lindau Disease
    Intervention:  
    Sponsor:   St. Jude Children's Research Hospital
    Recruiting

  • Conditions:   Bone Marrow Failure Syndromes;   Erythrocyte Disorder;   Leukocyte Disorder;   Hemostasis;   Blood Coagulation Disorder;   Sickle Cell Disease;   Dyskeratosis Congenita;   Diamond-Blackfan Anemia;   Congenital Thrombocytopenia;   Severe Congenital Neutropenia;   Fanconi Anemia
    Intervention:  
    Sponsors:   St. Jude Children's Research Hospital;   Boston Children’s Hospital;   Baylor College of Medicine;   University of Memphis
    Recruiting

  • Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi Anemia;   Thalassemia;   Sickle Cell Disease
    Intervention:  
    Sponsors:   University of California, San Francisco;   Thrasher Research Fund
    Recruiting

  • Condition:   Graft Versus Host Disease
    Intervention:   Drug: Abatacept
    Sponsors:   Emory University;   Thrasher Research Fund;   Sickle Cell Transplant Advocacy & Research Alliance (STAR)
    Recruiting

  • Condition:   Advanced Cancers
    Intervention:   Drug: LY2606368
    Sponsor:   Dana-Farber Cancer Institute
    Recruiting

  • Condition:   Advanced Solid Tumors
    Interventions:   Drug: SRA737, gemcitabine, cisplatin;   Drug: SRA737, gemcitabine
    Sponsor:   Sierra Oncology, Inc.
    Recruiting